- Report
- June 2024
- 144 Pages
Global
From €2208EUR$2,500USD£1,907GBP
- Report
- June 2024
- 149 Pages
Global
From €2208EUR$2,500USD£1,907GBP
- Report
- June 2024
- 134 Pages
Global
From €2208EUR$2,500USD£1,907GBP
- Report
- May 2024
- 175 Pages
Global
From €2208EUR$2,500USD£1,907GBP
- Report
- May 2024
- 178 Pages
Global
From €2208EUR$2,500USD£1,907GBP
- Report
- May 2024
- 163 Pages
Global
From €2208EUR$2,500USD£1,907GBP
- Report
- May 2024
- 174 Pages
Global
From €2208EUR$2,500USD£1,907GBP
- Report
- May 2024
- 167 Pages
Global
From €2208EUR$2,500USD£1,907GBP
- Report
- May 2024
- 170 Pages
Global
From €2208EUR$2,500USD£1,907GBP
- Report
- January 2024
- 166 Pages
Global
From €2208EUR$2,500USD£1,907GBP
- Report
- January 2024
- 161 Pages
Global
From €2208EUR$2,500USD£1,907GBP
- Report
- January 2024
- 156 Pages
Asia Pacific
From €2208EUR$2,500USD£1,907GBP
- Report
- December 2023
- 142 Pages
Brazil
From €2208EUR$2,500USD£1,907GBP
- Report
- December 2023
- 177 Pages
Global
From €2208EUR$2,500USD£1,907GBP
- Report
- November 2023
- 168 Pages
Global
From €2208EUR$2,500USD£1,907GBP
- Report
- November 2023
- 152 Pages
United States
From €2208EUR$2,500USD£1,907GBP
- Report
- November 2023
- 171 Pages
Global
From €2208EUR$2,500USD£1,907GBP
- Report
- October 2023
- 164 Pages
Global
From €2208EUR$2,500USD£1,907GBP
- Report
- September 2023
- 159 Pages
Global
From €2208EUR$2,500USD£1,907GBP
- Report
- September 2022
- 120 Pages
Global
From €2208EUR$2,500USD£1,907GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more